Company intelligence / Profile preview

Samhwa Biopharm

Siheung-si, Gyeonggi-do, South Korea

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Samhwa Biopharm is a South Korean pharmaceutical company specializing in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and chemical intermediates. Established in 1976, the company provides a range of small molecule products for respiratory, cardiovascular, gastrointestinal, and pain management indications. It operates a GMP-certified manufacturing facility in Gyeonggi-do and exports products to over 30 countries globally.

Therapeutic areas: ImmunologyCardiovascularNeurologyPulmonologyGastroenterologyMen's Health
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Samhwa Biopharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Samhwa Biopharm.

Explore the full profile